药品注册申请号:050717
申请类型:NDA (新药申请)
申请人:ZAMBON SPA
申请人全名:ZAMBON SPA ITALY
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 MONUROL FOSFOMYCIN TROMETHAMINE FOR SOLUTION;ORAL EQ 3GM BASE/PACKET Yes Yes AA 1996/12/19 1996/12/19 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2018/11/12 SUPPL-10(补充) Approval Labeling STANDARD
2018/05/31 SUPPL-9(补充) Approval Labeling STANDARD
2011/04/11 SUPPL-7(补充) Approval Labeling STANDARD Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.
2008/03/11 SUPPL-5(补充) Approval Labeling STANDARD
2002/12/18 SUPPL-4(补充) Approval Labeling STANDARD
1999/05/13 SUPPL-3(补充) Approval Manufacturing (CMC) STANDARD
1998/05/28 SUPPL-2(补充) Approval Manufacturing (CMC) STANDARD
1998/04/22 SUPPL-1(补充) Approval Manufacturing (CMC) STANDARD
1996/12/19 ORIG-1(原始申请) Approval Type 1 - New Molecular Entity STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:FOSFOMYCIN TROMETHAMINE 剂型/给药途径:FOR SOLUTION;ORAL 规格:EQ 3GM BASE/PACKET 治疗等效代码:AA
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
050717 001 NDA MONUROL FOSFOMYCIN TROMETHAMINE FOR SOLUTION;ORAL EQ 3GM BASE/PACKET Prescription Yes Yes AA 1996/12/19 ZAMBON SPA
212548 001 ANDA FOSFOMYCIN TROMETHAMINE FOSFOMYCIN TROMETHAMINE FOR SOLUTION;ORAL EQ 3GM BASE/PACKET Prescription No No AA 2020/10/06 XIROMED
214554 001 ANDA FOSFOMYCIN TROMETHAMINE FOSFOMYCIN TROMETHAMINE FOR SOLUTION;ORAL EQ 3GM BASE/PACKET Prescription No No AA 2021/10/21 ALKEM LABS LTD
211881 001 ANDA FOSFOMYCIN TROMETHAMINE FOSFOMYCIN TROMETHAMINE FOR SOLUTION;ORAL EQ 3GM BASE/PACKET Prescription No No AA 2022/01/26 CIPLA
216600 001 ANDA FOSFOMYCIN TROMETHAMINE FOSFOMYCIN TROMETHAMINE FOR SOLUTION;ORAL EQ 3GM BASE/PACKET Prescription No No AA 2024/03/25 AMNEAL
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database